Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

VKTX

Viking Therapeutics Inc

Nov 07 • 03:53PM ET

36.81

-0.47 -1.25 %

Healthcare • Biotechnology • USA • NASD

Peers: MDGL AKRO GLMD AKBA ATON ARDX BOLD TVRD EYPT FGEN

| Held by: XBI VTI VB VBK VXF SCHA IWR IWD VHT LABU

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-2.12	Insider Own	3.02%	Shs Outstand	112.45M	Perf Week	-3.35%
Market Cap	4.16B	Forward P/E	-	EPS next Y	-3.70	Insider Trans	-4.12%	Shs Float	109.62M	Perf Month	5.22%
Enterprise Value	3.45B	PEG	-	EPS next Q	-0.89	Inst Own	67.05%	Short Float	23.22%	Perf Quarter	-3.63%
Income	-237.39M	P/S	-	EPS this Y	-168.51%	Inst Trans	-1.88%	Short Ratio	3.87	Perf Half Y	33.59%
Sales	0.00M	P/B	5.80	EPS next Y	-36.39%	ROA	-28.31%	Short Interest	25.45M	Perf YTD	-8.54%
Book/sh	6.34	P/C	5.82	EPS next 5Y	-	ROE	-29.23%	52W High	70.41 -47.73%	Perf Year	-43.05%
Cash/sh	6.32	P/FCF	-	EPS past 3/5Y	-12.29% -23.00%	ROIC	-33.28%	52W Low	18.92 94.53%	Perf 3Y	757.93%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	7.94% 6.66%	Perf 5Y	558.41%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-126.16%	Oper. Margin	-	ATR (14)	2.44	Perf 10Y	552.57%
Dividend Ex-Date	-	Quick Ratio	28.34	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	59.11	Recom	1.11
Dividend Gr. 3/5Y	- -	Current Ratio	28.34	EPS Q/Q	-259.40%	SMA20	5.11%	Beta	0.65	Target Price	93.33
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	21.47%	Rel Volume	0.63	Prev Close	37.27
Employees	36	LT Debt/Eq	0.00	Earnings	Oct 22 AMC	SMA200	25.51%	Avg Volume	6.58M	Price	36.81
IPO	Apr 29, 2015	Option/Short	Yes / Yes	EPS/Sales Surpr.	-14.15% -	Trades		Volume	4,046,623	Change	-1.25%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-29-25	Initiated	Canaccord Genuity	Buy	$106
Apr-29-25	Initiated	Cantor Fitzgerald	Overweight	$104
Apr-08-25	Initiated	Goldman	Neutral	$30
Feb-13-25	Initiated	Scotiabank	Sector Outperform	$102
Feb-07-25	Initiated	Citigroup	Neutral	$38
Dec-02-24	Initiated	Piper Sandler	Overweight
Nov-22-24	Initiated	B. Riley Securities	Buy	$109
Nov-04-24	Reiterated	H.C. Wainwright	Buy	$90 → $102
Sep-11-24	Initiated	JP Morgan	Overweight	$80
Jun-27-24	Initiated	Morgan Stanley	Overweight	$105
May-16-24	Upgrade	Raymond James	Outperform → Strong Buy	$115 → $116
Mar-26-24	Reiterated	Oppenheimer	Outperform	$116 → $138
Mar-07-24	Initiated	Jefferies	Buy	$110
Feb-28-24	Reiterated	Oppenheimer	Outperform	$46 → $116
May-31-23	Resumed	ROTH MKM	Buy	$32
Mar-28-23	Reiterated	Maxim Group	Buy	$15 → $25
Mar-17-23	Initiated	Stifel	Buy	$22
Jul-29-21	Resumed	BTIG Research	Buy	$20
May-25-21	Downgrade	Raymond James	Strong Buy → Outperform	$27 → $12
Jun-05-20	Initiated	BMO Capital Markets	Outperform	$14

Show Previous Ratings

Today 10:44AM	LLY's GLP-1 Duo Boosts Sales Amid Rising Demand for Obesity Drugs (Zacks)
08:02AM	The Weight-Loss Drugs Craze Is Going Strong. But Stock Investors Should Know A Few Things. (Investor's Business Daily)
Nov-06-25 02:19PM	Jim Cramer Recommends Eli Lilly Over Viking Therapeutics (Insider Monkey)
07:05AM	Viking Therapeutics Highlights Clinical Data from VK2735 Obesity Program in Presentation at ObesityWeek 2025 (PR Newswire)
Nov-05-25 05:15AM	Here's Why Shares in Viking Therapeutics Shot Higher in October (Motley Fool) +5.31%
11:17PM	Loading…
Nov-04-25 11:17PM	Lightning Round: I lack a catalyst to recommend Zoom, says Jim Cramer (CNBC TV)
08:10PM	Billionaire Stanley Druckenmiller Dropped Nvidia and Palantir Stock and Is Piling into 2 Stocks Set to Win in One of the Decade's Hottest Growth Markets. (Motley Fool)
04:05PM	Viking Therapeutics to Participate at Upcoming Investor Conferences (PR Newswire)
01:35PM	Novo Nordisk Is Still Beating Pfizer in Battle Over Metsera (Barrons.com)
Nov-03-25 11:41AM	Novo Nordisk Before Q3 Earnings: How Should Investors Play the Stock? (Zacks) -5.46%
11:13AM	Viking Therapeutics Could Be Pharmas Next Big Buyout Target (24/7 Wall St.)
04:45AM	Prediction: The Next Eli Lilly Might Already Be Trading Under $50 (Motley Fool)
Nov-02-25 09:20AM	Should You Buy Viking Therapeutics Before Nov. 5? (Motley Fool)
Oct-31-25 11:18AM	3 Explosive Stocks With High Short Interest (24/7 Wall St.)
04:55AM	3 Promising Growth Stocks That Are Down Around 60% From Their Highs (Motley Fool)
10:40AM	Loading…
Oct-30-25 10:40AM	3 Explosive Stocks With High Short Interest (24/7 Wall St.) +8.38%
Oct-29-25 04:05PM	Viking Therapeutics to Highlight Clinical Data from VK2735 Obesity Program in Presentations at ObesityWeek 2025 (PR Newswire)
09:35AM	Skyworks upgraded, UnitedHealth downgraded: Wall Street's top analyst calls (The Fly)
Oct-27-25 09:30AM	Is Viking Therapeutics (VKTX) a Buy as Wall Street Analysts Look Optimistic? (Zacks)
09:05AM	Viking Therapeutics: High Risk, High Reward Play (MarketBeat)
Oct-23-25 04:13PM	Viking Bolts Higher On 'Lightning' Speed Enrollment In Obesity Studies (Investor's Business Daily) +7.96%
02:54PM	Viking Therapeutics Posts Wider-Than-Expected Loss in Q3, Sales Nil (Zacks)
02:36PM	Here's Why This Obesity Drug Company's Share Price Soared Today (Motley Fool)
10:39AM	Lilly Up 10% in a Month: Should You Buy, Sell or Hold the Stock? (Zacks)
09:55AM	How Will Ozempic and Wegovy Sales Aid NVO's Upcoming Q3 Results? (Zacks)
Oct-22-25 11:01PM	Viking Therapeutics Inc (VKTX) Q3 2025 Earnings Call Highlights: Strategic Advancements Amid ... (GuruFocus.com)
04:05PM	Viking Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update (PR Newswire)
Oct-21-25 07:05AM	Viking Therapeutics Announces Initiation of VK2735 Maintenance Dosing Clinical Trial in Patients with Obesity (PR Newswire)
Oct-20-25 04:20AM	These 3 Obesity Drug Stocks Are Set to Soar This Fall and Beyond (Motley Fool)
Oct-17-25 09:54PM	Viking Therapeutics (VKTX) Receives a Buy from Oppenheimer (Insider Monkey)
05:45PM	Loading…
05:45PM	Viking Therapeutics, Inc. (VKTX) Stock Dips While Market Gains: Key Facts (Zacks)
09:30AM	Pre-Q3 Earnings: Is Viking Therapeutics Stock a Portfolio Must-Have? (Zacks)
06:22AM	The Zacks Analyst Blog Highlights Eli Lilly, Novo Nordisk, Amgen and Viking Therapeutics (Zacks)
04:15AM	Eli Lilly vs. Viking Therapeutics Stock: Which Is the Best Growth Opportunity, According to Wall Street? (Motley Fool)
Oct-16-25 11:10AM	NVO, OMER Ink $2.1B Zaltenibart Deal to Bolster Rare Disease Portfolio (Zacks)
09:31AM	How Will Mounjaro and Zepbound Sales Aid Lilly's Upcoming Q3 Results? (Zacks)
07:45AM	Did Viking Therapeutics Just Say "Checkmate" to Eli Lilly? (Motley Fool)
Oct-15-25 04:05PM	Viking Therapeutics to Report Financial Results for Third Quarter 2025 on October 22, 2025 (PR Newswire) +6.26%
Oct-14-25 05:50PM	Viking Therapeutics, Inc. (VKTX) Registers a Bigger Fall Than the Market: Important Facts to Note (Zacks)
Oct-13-25 10:15AM	Down 44%, Should You Buy the Dip on Viking Therapeutics? (Motley Fool)
Oct-12-25 09:45AM	4 Healthcare Stocks to Buy Now (Motley Fool)
Oct-10-25 09:54AM	Can Novo Nordisk's Aggressive Deal-Making Offset Semaglutide Reliance? (Zacks)
Oct-09-25 01:37PM	Why Shares in Viking Therapeutics Surged This Week (Motley Fool) +8.06%
11:00AM	Is Novo Nordisk Stock a Sell Despite its 10% Price Rally in a Month? (Zacks)
Oct-08-25 05:45PM	Viking Therapeutics, Inc. (VKTX) Outpaces Stock Market Gains: What You Should Know (Zacks)
12:57AM	Where is Viking Therapeutics (VKTX) Headed According to Analysts? (Insider Monkey)
Oct-05-25 04:31PM	The Best Stocks to Invest $1,000 in Right Now (Motley Fool)
Oct-02-25 05:45PM	Viking Therapeutics, Inc. (VKTX) Beats Stock Market Upswing: What Investors Need to Know (Zacks) +6.60%
Sep-30-25 10:45AM	Can NVO Maintain Obesity Leadership With Next-Generation Candidates? (Zacks)
09:15AM	Why This Beaten-Down GLP-1 Stock Could Be a Steal (Motley Fool)
04:12AM	BTIG Reiterates a Buy Rating on Viking Therapeutics (VKTX) (Insider Monkey)
Sep-25-25 05:45PM	Viking Therapeutics, Inc. (VKTX) Declines More Than Market: Some Information for Investors (Zacks) -5.78%
09:30AM	Brokers Suggest Investing in Viking Therapeutics (VKTX): Read This Before Placing a Bet (Zacks)
09:15AM	Can Viking Therapeutics Hold Its Edge as Obesity Rivalry Heats Up? (Zacks)
04:12AM	Pfizer Is Buying Weight Loss Biotech Metsera. Here's Why Viking Therapeutics Shareholders May Be Cheering. (Motley Fool)
Sep-24-25 12:25PM	LLY vs. NVO: Which Obesity Drug Stock Is the Better Buy Now? (Zacks) +6.65%
Sep-23-25 05:50PM	Viking Therapeutics, Inc. (VKTX) Falls More Steeply Than Broader Market: What Investors Need to Know (Zacks)
Sep-19-25 10:51AM	Can Novo Nordisk Hold Its Edge as the GLP-1 Battle With LLY Heats Up? (Zacks)
04:40AM	Prediction: Viking Therapeutics Stock Will Double in Value Within the Next 12 Months (Motley Fool)
Sep-18-25 11:20AM	LLY's Orforglipron Tops NVO's Oral Pill in Diabetes Study: What's Next? (Zacks) +12.78%
Sep-17-25 06:22PM	Biotech Breakouts: 3 Stocks With Massive Upside Potential (MarketBeat)
09:53AM	NVO Stock Rises on Upbeat Phase III Data for Cagrilintide in Obesity (Zacks)
Sep-16-25 02:04PM	Viking Therapeutics, Inc. (VKTX): A Bull Case Theory (Insider Monkey)
12:58PM	AMGN vs. VKTX: Which Biotech Stock Is the Better Obesity Play? (Zacks)
08:54AM	Will Rybelsus' Updated EU Label Propel Fresh Growth Potential for NVO? (Zacks)
Sep-15-25 05:45PM	Viking Therapeutics, Inc. (VKTX) Stock Falls Amid Market Uptick: What Investors Need to Know (Zacks)
11:08AM	Lilly Moves Past 50-Day SMA: Should You Consider Buying the Stock Now? (Zacks)
Sep-11-25 03:43PM	Prediction: After a Tough Summer for Healthcare Stocks, These 2 Companies Can Make a Comeback (Motley Fool)
10:02AM	Where Does VKTX Stock Stand After the Obesity Pill Setback? (Zacks)
Sep-10-25 10:28AM	Is NVO's Major Restructuring Plan an Indication to Sell the Stock? (Zacks)
Sep-09-25 09:30AM	Wall Street Bulls Look Optimistic About Viking Therapeutics (VKTX): Should You Buy? (Zacks)
Sep-08-25 07:33PM	Viking Therapeutics, Inc. (VKTX) Stock Drops Despite Market Gains: Important Facts to Note (Zacks) -5.56%
11:58AM	Jim Cramer Recommends Eli Lilly Over Viking Therapeutics (Insider Monkey)
Sep-07-25 11:14AM	Think It's Too Late to Buy This Leading Biotech Stock? Here's Why There's Still Time. (Motley Fool)
Sep-05-25 04:10AM	Down 34%, Should You Buy the Dip on Viking Therapeutics? (Motley Fool)
Sep-04-25 09:00AM	Prediction: These 2 Biotech Stocks Could Double in the Next 5 Years (Motley Fool)
Sep-03-25 01:48PM	The Problem With Weight Loss Stocks (Motley Fool)
Sep-02-25 10:30AM	Viking Therapeutics Loses 20% in a Month: How to Play the Stock (Zacks)
Sep-01-25 10:54AM	NVO's Wegovy vs. LLY's Tirzepatide: Who Leads in Heart Risk Reduction? (Zacks)
Aug-29-25 05:45PM	Viking Therapeutics, Inc. (VKTX) Suffers a Larger Drop Than the General Market: Key Insights (Zacks)
04:26AM	2 Beaten-Down Stocks That Could Rocket 142% to 222% Higher, According to Wall Street Analysts (Motley Fool)
Aug-28-25 06:42PM	Why Viking Therapeutics Stock Popped Nearly 4% Today (Motley Fool)
04:30PM	Viking Therapeutics to Participate at Upcoming Investor Conferences (PR Newswire)
Aug-27-25 10:52AM	Novo Nordisk vs. Viking Therapeutics: Which GLP-1 Stock is a Safer Bet? (Zacks)
10:00AM	Billionaire Stanley Druckenmiller Just Bought the Dip on This Beaten-Down GLP-1 Stock (Hint: It's Not Eli Lilly or Novo Nordisk) (Motley Fool)
08:11AM	Does Lilly's New Obesity Pill Data Put It Back in the Weight Game? (Zacks)
Aug-26-25 04:08PM	Eli Lilly's 'Surprising Development' In Obesity Just Slammed Novo Stock (Investor's Business Daily)
11:09AM	Can Novo Nordisk Offset GLP-1 Pressures With Rare Disease Wins? (Zacks)
09:47AM	Eli Lilly Scores Another Weight-Loss Win; Viking, Novo Stocks Slump (Investor's Business Daily)
06:15AM	Viking Therapeutics: What's Next? (Motley Fool)
Aug-24-25 08:45AM	2 Biotech Stocks That Could Soar 21% and 245% According to Wall Street's Top Analysts (Motley Fool)
Aug-23-25 05:00AM	Investing.coms stocks of the week (Investing.com)
Aug-22-25 11:30AM	Viking Therapeutics (VKTX) Down 23.4% Since Last Earnings Report: Can It Rebound? (Zacks)
10:21AM	Here's Why Shares in Viking Therapeutics Crashed This Week (Motley Fool)
08:49AM	Is Orforglipron Pill Setback End of the Road for LLY's Obesity Plans? (Zacks)
Aug-21-25 12:53PM	Viking Therapeutics (VKTX) Rebounds on Bargain-Hunting. Are You Missing Out? (Insider Monkey)
12:05PM	Post Obesity Pill Results Reveal: Buy, Sell or Hold VKTX Stock? (Zacks)
07:39AM	Healthcare Stocks Are the Cheapest They've Been in 30 Years-and a Turnaround May Have Already Started (Barrons.com)
05:24AM	Is Beaten-Down Viking Therapeutics Stock a Buy on the Dip? (Motley Fool)
Aug-20-25 12:59PM	Here's Why Viking Therapeutics Bounced Back Today (Motley Fool) +5.46%

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Mancini Marianna	Chief Operating Officer	Oct 28 '25	Sale	35.00	6,185	216,492	382,467	Oct 28 07:51 PM
Rowland Charles A Jr	Director	Oct 27 '25	Sale	35.57	60,000	2,134,278	30,000	Oct 28 07:49 PM
Lian Brian	President & CEO	Oct 28 '25	Sale	35.01	38,989	1,364,923	2,419,109	Oct 28 07:48 PM
ZANTE GREG	Chief Financial Officer	Oct 28 '25	Sale	35.00	6,185	216,481	173,592	Oct 28 07:47 PM
GREG ZANTE	Officer	Oct 28 '25	Proposed Sale	35.01	6,185	216,531		Oct 28 04:34 PM
MARIANNA MANCINI	Officer	Oct 28 '25	Proposed Sale	35.00	6,185	216,492		Oct 28 04:32 PM
BRIAN LIAN	Officer	Oct 28 '25	Proposed Sale	35.01	38,989	1,364,923		Oct 28 04:27 PM
CHARLES A ROWLAND JR.	Director	Oct 27 '25	Proposed Sale	35.57	60,000	2,134,278		Oct 27 04:25 PM
Lian Brian	President & CEO	Jul 03 '25	Sale	27.80	26,889	747,633	2,388,014	Jul 03 03:31 PM
ZANTE GREG	Chief Financial Officer	Jul 03 '25	Sale	27.76	4,266	118,428	168,660	Jul 03 03:31 PM
Mancini Marianna	Chief Operating Officer	Jul 03 '25	Sale	27.77	4,266	118,473	377,535	Jul 03 03:30 PM
GREG ZANTE	Officer	Jul 03 '25	Proposed Sale	27.76	4,266	118,428		Jul 03 01:07 PM
MARIANNA MANCINI	Officer	Jul 03 '25	Proposed Sale	27.77	4,266	118,473		Jul 03 01:05 PM
BRIAN LIAN	Officer	Jul 03 '25	Proposed Sale	27.80	26,889	747,633		Jul 03 01:01 PM
FOEHR MATTHEW W	Director	Apr 11 '25	Option Exercise	8.00	20,786	166,288	132,036	Apr 14 07:26 PM
Rouan Sarah Kathryn	Director	Mar 31 '25	Buy	24.15	1,240	29,943	1,240	Apr 02 06:29 PM
Lian Brian	President & CEO	Jan 06 '25	Sale	42.75	194,490	8,313,601	2,366,570	Jan 06 08:16 PM
Mancini Marianna	Chief Operating Officer	Jan 06 '25	Sale	42.75	54,215	2,317,599	374,134	Jan 06 08:15 PM
ZANTE GREG	Chief Financial Officer	Jan 06 '25	Sale	42.75	50,309	2,150,595	165,259	Jan 06 08:14 PM
GREG ZANTE	Officer	Jan 06 '25	Proposed Sale	42.75	50,309	2,150,594		Jan 06 05:32 PM
MARIANNA MANCINI	Officer	Jan 06 '25	Proposed Sale	42.75	54,215	2,317,599		Jan 06 05:25 PM
BRIAN LIAN	Officer	Jan 06 '25	Proposed Sale	42.75	194,490	8,313,611		Jan 06 05:16 PM
MACARTNEY LAWSON	Director	Nov 08 '24	Option Exercise	5.80	2,000	11,600	49,965	Nov 08 06:22 PM
MACARTNEY LAWSON	Director	Nov 08 '24	Sale	68.67	2,000	137,333	47,965	Nov 08 06:22 PM
LAWSON MACARTNEY	Director	Nov 08 '24	Proposed Sale	68.67	2,000	137,333		Nov 08 06:13 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

VKTX

Viking Therapeutics Inc

Upgrade your FINVIZ experience